The global neurodegenerative drugs market is anticipated to grow at a CAGR of 6.8% during the forecast period (2022-2028). Neurodegenerative diseases are the chronic conditions that result in progressive degeneration or death of nerve cells. This causes problems with mental functioning known as dementias; mobility issues which is referred to as ataxias; and negatively impacts […]
